Skip to main content
Clinical Trials/NCT02466945
NCT02466945
Unknown
Not Applicable

Oral and Dental Tolerance and Efficacy on Dentinal Hypersensitivity of a Dental Gel, on Adults

Pierre Fabre Dermo Cosmetique1 site in 1 country55 target enrollmentSeptember 2015

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Dentinal Hypersensitivity
Sponsor
Pierre Fabre Dermo Cosmetique
Enrollment
55
Locations
1
Primary Endpoint
Global tolerance according to a 5-point grading scale taking into account physical signs observed and graded by the dentist and functionnal signs observed and graded by the patient
Last Updated
10 years ago

Overview

Brief Summary

The aim of this clinical trial is to evaluate the tolerance and efficacy of a dental gel in patients with dentinal hypersensitivity.

Detailed Description

The aim of this clinical trial is to evaluate the tolerance and efficacy of dental gel V063B-DP3003 in patients with dentinal hypersensitivity, under normal conditions of use, under dentist control. The primary objective of this study is to evaluate the global oral and dental tolerance of the studied product after 28 days of use. Some efficacy objectives have been added to observe the efficacy of the dental gel. The dentinal hypersensitivity will be evaluated by the investigator with a thermal stimulus on two sensitive teeth selected by the investigator.

Registry
clinicaltrials.gov
Start Date
September 2015
End Date
June 2016
Last Updated
10 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
Pierre Fabre Dermo Cosmetique
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Male or female
  • Aged between18 and 70 years included
  • Having signed his/her written informed consent,
  • If it is a woman of childbearing potential :
  • Must have been using an effective method of contraception Negative Urine pregnancy test at inclusion,
  • Subject who can be reached in case of emergency,
  • Subject willing to be compliant to the protocol,
  • Subject able to fill out the daily log and the questionnaire.
  • Subject with at least 20 natural teeth (especially on the studied teeth),
  • Subject with an healthy gum status according to the investigator,

Exclusion Criteria

  • Subject participating to any other biomedical research projects,
  • For women : Pregnant or breastfeeding,
  • Has forfeited his/her freedom by administrative or legal award or is under guardianship,
  • Subject who, in the judgement of the investigator, is not likely to be compliant during the study,
  • Subject unable to understand the information given (for linguistic or psychiatric reasons) and to give his/her consent in writing,
  • Subject having dental braces
  • Subject having immune system disorder,
  • Subject having asthma,
  • Subject having a disease liable to interfere with study data according to the investigator,
  • Subject with teeth showing evidence of facets of attrition, premature contact, cracked enamel on the tooth to be studied and adjacent teeth,

Outcomes

Primary Outcomes

Global tolerance according to a 5-point grading scale taking into account physical signs observed and graded by the dentist and functionnal signs observed and graded by the patient

Time Frame: after 28 days

The global tolerance of the product is assessed by the dentist after 28 days of use, rated on a 5-point grading scale(good tolerance, very good tolerance, good tolerance, moderate tolerance) . The results of the global tolerance will take into account the physical signs observed by the dentist and the functional signs observed by the patients during the study

Secondary Outcomes

  • Tolerance with the record of functionnal signs reported by the dentist and physical signs reported by the patient.(during 28 days)
  • Acceptability of the product assessed with a questionnaire(during 28 days)
  • Cold air stimulus score on the schiff cold air index as a mesure of immediate efficacy(5 and 60 minutes after application at day 1)
  • Cold air stimulus score on the schiff cold air index as a mesure of efficacy(between baseline and day 28)
  • Cold air stimulus score on the schiff cold air index as a mesure of short term efficacy(efficacy at day 4 and day 6)

Study Sites (1)

Loading locations...

Similar Trials